PharmaCyte Biotech, Inc. Quarterly Stockholders' Equity Attributable to Parent in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
PharmaCyte Biotech, Inc. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q1 2010 to Q2 2024.
  • PharmaCyte Biotech, Inc. Stockholders' Equity Attributable to Parent for the quarter ending July 31, 2024 was $47.7M, a 21.7% increase year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $47.7M +$8.51M +21.7% Jul 31, 2024 10-Q 2024-09-17
Q1 2024 $27.6M -$45M -62% Apr 30, 2024 10-Q 2024-09-17
Q4 2023 $31.4M -$45.7M -59.3% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $36.8M -$44.3M -54.6% Oct 31, 2023 10-Q 2024-03-18
Q2 2023 $39.2M -$47.1M -54.6% Jul 31, 2023 10-Q 2024-09-17
Q1 2023 $72.7M -$17.2M -19.2% Apr 30, 2023 10-Q 2024-09-17
Q4 2022 $77.1M -$14.2M -15.6% Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $81M -$11.1M -12% Oct 31, 2022 10-Q 2024-03-18
Q2 2022 $86.3M +$80.6M +1411% Jul 31, 2022 10-Q 2024-03-18
Q1 2022 $89.9M +$83.2M +1246% Apr 30, 2022 10-K 2024-08-13
Q4 2021 $91.3M +$83.7M +1100% Jan 31, 2022 10-Q 2023-03-16
Q3 2021 $92.1M +$83.8M +1013% Oct 31, 2021 10-Q 2023-03-16
Q2 2021 $5.71M -$533K -8.53% Jul 31, 2021 10-Q 2023-03-16
Q1 2021 $6.68M +$1.59M +31.3% Apr 30, 2021 10-K 2023-07-31
Q4 2020 $7.61M +$3.29M +76.3% Jan 31, 2021 10-Q 2022-03-15
Q3 2020 $8.28M +$3.74M +82.5% Oct 31, 2020 10-Q 2022-03-15
Q2 2020 $6.25M +$1.25M +24.9% Jul 31, 2020 10-Q 2022-03-15
Q1 2020 $5.09M +$49.4K +0.98% Apr 30, 2020 10-K 2022-07-28
Q4 2019 $4.32M -$1.05M -19.5% Jan 31, 2020 10-Q 2021-03-12
Q3 2019 $4.53M -$870K -16.1% Oct 31, 2019 10-Q 2021-03-12
Q2 2019 $5M -$1.2M -19.3% Jul 31, 2019 10-Q 2021-03-12
Q1 2019 $5.04M -$729K -12.6% Apr 30, 2019 10-K 2021-08-10
Q4 2018 $5.37M -$472K -8.09% Jan 31, 2019 10-Q 2020-03-13
Q3 2018 $5.4M -$1.94M -26.5% Oct 31, 2018 10-Q 2020-03-13
Q2 2018 $6.2M -$2.46M -28.4% Jul 31, 2018 10-Q 2020-03-13
Q1 2018 $5.77M -$2.32M -28.7% Apr 30, 2018 10-K 2020-08-13
Q4 2017 $5.84M -$1.2M -17% Jan 31, 2018 10-Q 2019-03-14
Q3 2017 $7.35M +$1.07M +17% Oct 31, 2017 10-Q 2019-03-14
Q2 2017 $8.66M +$1.59M +22.5% Jul 31, 2017 10-Q 2019-03-14
Q1 2017 $8.09M +$1.56M +24% Apr 30, 2017 10-K 2019-08-13
Q4 2016 $7.04M +$100K +1.45% Jan 31, 2017 10-Q/A 2017-03-13
Q3 2016 $6.28M -$615K -8.91% Oct 31, 2016 10-Q 2016-12-02
Q2 2016 $7.07M -$762K -9.73% Jul 31, 2016 10-Q 2016-09-06
Q1 2016 $6.52M -$1.25M -16.1% Apr 30, 2016 10-K 2018-07-20
Q4 2015 $6.94M +$688K +11% Jan 31, 2016 10-Q 2016-03-08
Q3 2015 $6.9M +$515K +8.07% Oct 31, 2015 10-Q/A 2016-01-19
Q2 2015 $7.83M +$1.54K +0.02% Jul 31, 2015 10-Q/A 2016-01-19
Q1 2015 $7.78M -$1.17M -13% Apr 30, 2015 10-K 2017-07-27
Q4 2014 $6.25M +$1.06M +20.5% Jan 31, 2015 10-Q 2015-03-13
Q3 2014 $6.38M +$2.78M +77.1% Oct 31, 2014 10-Q 2014-12-15
Q2 2014 $7.83M +$5.93M +312% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 $8.94M +$10.4M Apr 30, 2014 10-K 2016-07-29
Q4 2013 $5.18M +$7.21M Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $3.6M +$5.66M Oct 31, 2013 10-Q 2013-12-16
Q2 2013 $1.9M +$4.27M Jul 31, 2013 10-Q 2013-09-16
Q1 2013 -$1.5M +$778K +34.1% Apr 30, 2013 10-K 2016-07-29
Q4 2012 -$2.03M +$218K +9.72% Jan 31, 2013 10-Q 2013-03-26
Q3 2012 -$2.05M +$321K +13.5% Oct 31, 2012 10-Q 2012-12-26
Q2 2012 -$2.37M +$33.5K +1.39% Jul 31, 2012 10-Q 2012-09-19
Q1 2012 -$2.28M +$449K +16.5% Apr 30, 2012 10-K/A 2016-01-19
Q4 2011 -$2.25M Jan 31, 2012 10-Q 2012-03-21
Q3 2011 -$2.38M Oct 31, 2011 10-Q 2011-12-15
Q2 2011 -$2.41M Jul 31, 2011 10-Q/A 2011-09-20
Q1 2011 -$2.73M -$278K -11.3% Apr 30, 2011 10-K 2013-07-29
Q1 2010 -$2.45M Apr 30, 2010 10-K 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.